APPLIED GENOMIC TECHNOLOGY CAPITAL FUNDS

Applied Genomic Technology Capital Funds (www.agtcfunds.com) is a new venture capital group focused on investment opportunities enabled by the genomic revolution. AGTC Funds will invest in start-up and early stage companies that apply genomic information and technologies to develop products or services that create significant shareholder value. Formed by NewcoGen Group, in conjunction with OneLiberty Ventures, AGTC Funds' limited partners include both institutional investors and corporations with a strategic interest in genomics. As the first specialty fund focused on this sector, AGTC expects to play a leadership role in selecting, funding and developing new genomics-application companies.